As Azar Pays Lip Service to the Cost of Pharmaceuticals in America, Drug Company Profits Continue to Soar
Drug Company AbbVie’s $5 Billion Stock Buyback Announced Last Week Latest Example of Pharmaceutical Companies Going Unchecked Under Azar’s Watch ... Read More